© 2022 MJH Life Sciences™ , Dermatology Times and Multimedia Medical, LLC. All rights reserved.
Antigenics Inc. has announced its experimental cancer vaccine Oncophage improved post-surgery results for patients with metastatic melanoma, with one of 18 patients remaining disease-free for almost 15 months.